Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

Understanding COVID-19 and varying responses across the globe

At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global...

Blue Latitude Health

- PMLiVE

Moderna’s COVID-19 vaccine enters pivotal phase 3 trial

Large-scale study will evaluate vaccine in 30,000 participants

- PMLiVE

Pfizer, BioNTech identify and advance lead COVID-19 vaccine candidate

Companies pick the most promising candidate to take into phase 2/3

AstraZeneca AZ

Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

Follows initial deal agreed in June

Persuasive technology: designing behaviour change initiatives for digital

By Michelle Kelly

- PMLiVE

Origins Insights: views from the team

First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities.

Bedrock Healthcare Communications

When community can inspire a social media movement

Natalie Karaminas, Account Director, PR & Creative Communications at Havas Life Medicom, shares the value of social media in building online communities to spark a movement

Havas Life London

- PMLiVE

GSK’s anti-BCMA drug leads crowded CHMP recommendations

Ten new drugs receive positive recommendations for approval

- PMLiVE

Novartis’ Sandoz division announces antibiotic manufacturing plan

Joint investment agreed with the Austrian federal government

- PMLiVE

How to create real, lasting change after COVID-19

By David Thompson and Paul Tanner

- PMLiVE

New hires at EMA, Gilead and BeiGene

EMA gains a new executive director, Gilead appoints a new senior vice president and BeiGene hires a new chief business exec

- PMLiVE

Biogen plans Spinraza study in SMA patients treated with Novartis’ Zolgensma

Company aims to extend market reach

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links